Detalhe da pesquisa
1.
MEETING HIGHLIGHTS: THE THIRD MARIE SKLODOWSKA-CURIE SYMPOSIUM ON CANCER RESEARCH AND CARE AT ROSWELL PARK COMPREHENSIVE CANCER CENTER, BUFFALO, NY, SEPTEMBER 20-22, 2023.
Wiad Lek
; 76(12): 2543-2555, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38290016
2.
Siglec-5 is an inhibitory immune checkpoint molecule for human T cells.
Immunology
; 166(2): 238-248, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35290663
3.
Human CD36hi monocytes induce Foxp3+ CD25+ T cells with regulatory functions from CD4 and CD8 subsets.
Immunology
; 163(3): 293-309, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33524161
4.
Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cells.
J Biol Chem
; 294(23): 9198-9212, 2019 06 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30971427
5.
T cell receptor cross-reactivity expanded by dramatic peptide-MHC adaptability.
Nat Chem Biol
; 14(10): 934-942, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30224695
6.
Targeting Cancer with Genetically Engineered TCR T Cells.
Recent Results Cancer Res
; 214: 129-151, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31473851
7.
Improving T Cell Receptor On-Target Specificity via Structure-Guided Design.
Mol Ther
; 27(2): 300-313, 2019 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30617019
8.
How an alloreactive T-cell receptor achieves peptide and MHC specificity.
Proc Natl Acad Sci U S A
; 114(24): E4792-E4801, 2017 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28572406
9.
Understanding TCR affinity, antigen specificity, and cross-reactivity to improve TCR gene-modified T cells for cancer immunotherapy.
Cancer Immunol Immunother
; 68(11): 1881-1889, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31595324
10.
Altered Peptide Ligands Impact the Diversity of Polyfunctional Phenotypes in T Cell Receptor Gene-Modified T Cells.
Mol Ther
; 26(4): 996-1007, 2018 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29503203
11.
How structural adaptability exists alongside HLA-A2 bias in the human αß TCR repertoire.
Proc Natl Acad Sci U S A
; 113(9): E1276-85, 2016 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26884163
12.
N-acetyl cysteine protects anti-melanoma cytotoxic T cells from exhaustion induced by rapid expansion via the downmodulation of Foxo1 in an Akt-dependent manner.
Cancer Immunol Immunother
; 67(4): 691-702, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29396710
13.
Correction to: Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells.
Cancer Immunol Immunother
; 67(2): 327, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29264697
14.
Clinical and immunologic evaluation of three metastatic melanoma patients treated with autologous melanoma-reactive TCR-transduced T cells.
Cancer Immunol Immunother
; 67(2): 311-325, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29052782
15.
Activated human Foxp3+ regulatory T cells produce membrane-bound TNF.
Cytokine
; 111: 454-459, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-29885993
16.
Critical biological parameters modulate affinity as a determinant of function in T-cell receptor gene-modified T-cells.
Cancer Immunol Immunother
; 66(11): 1411-1424, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28634816
17.
Enhanced stimulation of human tumor-specific T cells by dendritic cells matured in the presence of interferon-γ and multiple toll-like receptor agonists.
Cancer Immunol Immunother
; 66(10): 1333-1344, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28601925
18.
Cutting Edge: AhR Is a Molecular Target of Calcitriol in Human T Cells.
J Immunol
; 195(6): 2520-3, 2015 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26276877
19.
Strategies to genetically engineer T cells for cancer immunotherapy.
Cancer Immunol Immunother
; 65(6): 631-49, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27138532
20.
TCR gene-modified T cells can efficiently treat established hepatitis C-associated hepatocellular carcinoma tumors.
Cancer Immunol Immunother
; 65(3): 293-304, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26842125